Kymco has announced that it has formally terminated its distribution agreement with Masco Ltd.
The company said that Kymco Healthcare UK, which is 100% owned by Kymco Taiwan, will continue to service and support existing Kymco dealers and customers, with the aim of keeping any disruption to a minimum.
In a statement on its website, it urged customers to contact Kymco Healthcare if they need any further support or assistance for the product and after-service during what they call a “transitional period”.
Masco ceased trading on 4 July after enduring cashflow difficulties. It was the sole UK importer for Kymco Motorcycles and liquidators at the time said they would be working closely with Kymco to ensure that a new importer could be appointed to supply new products in the UK.
AMP has contacted Kymco Mobility boss Mark Hermolle for clarification of whether the arrangement has any impact on its mobility business. However, we were still awaiting a response at the time of publication.
Mr Hermolle (pictured) did tell a motorcycle trade website last week that taking on the distributorship of the former Masco business would essentially give the Bridgend firm an expanded structure to run alongside its mobility scooter business.
Asked what was Kymco Healthcare’s experience in dealing with the motorcycle and scooter market, he replied: “Kymco Healthcare UK Ltd is very experienced at supporting mobility dealers and is a market leader in this field. The new structure for ‘KYMCO UK’ will include a division focused on motorcycles, scooters and quads.”
Kymco Healthcare has been manufacturing high quality mobility scooters for more than 15 years. Its full range is also available through the Motability Scheme of which it claims to be the leading supplier.